Loading organizations...

§ Venture Capital · USA
Venture capital firm investing in pre-seed startups with cutting-edge technologies, focused on deep tech, AI, biotech, robotics.
Key people at Divergent Capital.
Divergent Capital is a New York-based venture capital firm that invests in pre-seed stage startups developing cutting-edge technologies across artificial intelligence, biotechnology, and robotics. The firm focuses on high-conviction deep tech investments, typically writing initial checks ranging from $250,000 to $750,000 to support technical founders solving complex industry problems. Actively deploying capital from its initial fund, the organization targets a concentrated portfolio of 20 to 25 companies and currently manages between eight and twelve active investments. Divergent Capital has backed several emerging technology companies, participating in recent funding rounds such as a $10 million Series A financing for Baton. Additional portfolio companies include Paterna Biosciences, PHNX Materials, and Motif Neurotech, which have all recently secured multi-million dollar seed investments. The venture firm was founded in 2020 by Katie Shea and Lucy Wang.
Divergent Capital is a New York-based early-stage venture capital firm founded in 2020 that focuses on investing in bold founders developing category-defining technologies, with a particular emphasis on fintech, insurtech, software, AI, biotech, and other emerging sectors. The firm typically makes pre-seed investments ranging from $250,000 to $750,000, aiming to back 20-25 companies with deep engagement and strategic guidance. Divergent Capital prioritizes founders who have a strong personal connection to the problems they are solving and emphasizes practical, product-driven growth over market size alone. Their hands-on approach includes support in product development, go-to-market strategies, and scaling, helping startups accelerate growth and innovation in the fintech and insurtech spaces as well as beyond[1][2][3].
Divergent Capital was founded in 2020 by Katie Shea (Co-Founder and Managing Partner) and Lucy Wang (Co-Founder and General Partner) in New York. Since its inception, the firm has evolved to focus on pre-seed investments in deeply technical and scientific founders, including those working in AI, biotech, climatetech, and infrastructure sectors. The founders brought a vision of supporting innovative technologies often outside traditional Silicon Valley networks, emphasizing hands-on partnership with startups to help them scale effectively. The firm’s early focus on pre-revenue and pre-launch companies reflects a commitment to nurturing innovation from the ground up[1][3][4].
Divergent Capital rides the wave of early-stage innovation in fintech and insurtech, sectors undergoing rapid transformation due to digital disruption, regulatory changes, and evolving consumer demands. The timing is critical as financial services increasingly integrate AI, machine learning, and automation, creating opportunities for startups to redefine traditional models. By focusing on pre-seed investments and supporting founders with deep domain expertise, Divergent Capital helps catalyze innovation that might otherwise be overlooked by larger, later-stage funds. Their presence strengthens the startup ecosystem by diversifying geographic and sectoral representation, particularly outside Silicon Valley, and by fostering technologies that address real-world financial and insurance challenges[1][2][3].
Looking ahead, Divergent Capital is poised to continue expanding its portfolio in fintech and insurtech, leveraging emerging trends such as AI-driven financial services, embedded insurance, and decentralized finance. As regulatory frameworks evolve and consumer expectations shift, the firm’s hands-on approach and focus on founders with authentic problem insights will likely enhance its influence in shaping category-defining startups. The firm’s commitment to early-stage, high-conviction investments positions it well to capitalize on nascent technologies and business models that could transform financial and insurance sectors over the next decade[1][2][3][4]. This trajectory ties back to their founding mission of supporting innovative founders who challenge the status quo with practical, product-driven solutions.
Key people at Divergent Capital.
Divergent Capital has more than 26 tracked investments across 24 companies. The latest tracked deal is $10.0M Seed in Opto Biosystems in November 2025.